6.755

0.22% 0.015

Neuehealth Inc (NEUE)

Overview News Price History Discussions Forecast

Neuehealth Inc stock is traded at $6.755, with a volume of 57,900. It is up +0.22% in the last 24 hours and down -8.00% over the past month. NeueHealth Inc is a value driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated care. By uniquely aligning the interests of health consumers, providers, and payors, NeueHealth helps to make healthcare accessible and affordable to all populations across the ACA Marketplace, Medicare, and Medicaid. It also enables independent providers and medical groups to thrive in performance-based arrangements through a suite of technology and services scaled centrally and deployed locally.

Previous Close:

$6.74

Open:

$6.76

24h Volume:

57,900

Relative Volume:

1.61

Market Cap:

$56.43M

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

-6.70%

1M Performance:

-8.00%

6M Performance:

+28.30%

1Y Performance:

-7.59%

1-Day Range:

$6.625

$6.9699

1-Week Range:

$6.625

$7.2899

52-Week Range:

$3.79

$7.66

Neuehealth Inc Stock (NEUE) Company Profile

Name

Neuehealth Inc

Sector

Healthcare (1172)

Industry

Healthcare Plans (14)

Phone

612-238-1321

Address

9250 NW 36TH STREET, DORAL

Employee

1,252

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

NEUE's Discussions on Twitter

Compare NEUE with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
NEUE Neuehealth Inc	6.625	56.43M	0	0	0	0.00
UNH Unitedhealth Group Inc	481.17	444.27B	400.28B	14.41B	20.71B	15.50
ELV Elevance Health Inc	417.00	95.05B	176.81B	5.98B	4.55B	25.61
CI Cigna Group	311.57	85.83B	244.38B	3.43B	8.96B	12.24
CVS Cvs Health Corp	65.60	83.68B	372.81B	4.61B	6.33B	3.66
HUM Humana Inc	250.75	30.23B	117.76B	1.21B	2.39B	9.95

Neuehealth Inc Stock (NEUE) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-11-22	Downgrade	JP Morgan	Neutral → Underweight
Mar-29-22	Downgrade	JP Morgan	Overweight → Neutral
Mar-04-22	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Mar-02-22	Downgrade	BofA Securities	Buy → Underperform
Jan-10-22	Resumed	Citigroup	Neutral
Dec-16-21	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Dec-14-21	Initiated	Goldman	Neutral
Dec-10-21	Upgrade	JP Morgan	Neutral → Overweight
Nov-12-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Nov-02-21	Downgrade	Cowen	Outperform → Market Perform
Nov-01-21	Downgrade	Citigroup	Buy → Neutral
Sep-10-21	Initiated	Cowen	Outperform
Aug-04-21	Upgrade	Citigroup	Neutral → Buy
Aug-04-21	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Jul-19-21	Initiated	Goldman	Buy
Jul-19-21	Initiated	JP Morgan	Neutral
Jul-19-21	Initiated	Morgan Stanley	Equal-Weight
Jul-19-21	Initiated	Piper Sandler	Overweight
Jul-19-21	Initiated	RBC Capital Mkts	Outperform
Jul-19-21	Initiated	Wolfe Research	Peer Perform

View All

Neuehealth Inc Stock (NEUE) Latest News

02:13 AM

NeueHealth (NEUE) Expected to Announce Quarterly Earnings on Thursday - Defense World

02:13 AM

Mar 11, 2025

NeueHealth GC Craig Michael sells $8,929 in stock By Investing.com - Investing.com South Africa

Mar 11, 2025

NeueHealth EVP Tomas Orozco sells $4,599 in stock By Investing.com - Investing.com UK

Mar 11, 2025

Mar 03, 2025

NeueHealth (NEUE) Projected to Post Earnings on Wednesday - Defense World

Mar 03, 2025

Feb 26, 2025

NeueHealth to Host Fourth Quarter 2024 Earnings Conference Call on March 20, 2025 - The Bakersfield Californian

Feb 26, 2025

When Will NeueHealth Reveal Its Q4 Performance? Key Date for Investors - StockTitan

Feb 26, 2025

Feb 19, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LBRDA, AMPS, NEUE on Behalf of Shareholders - Marketscreener.com

Feb 19, 2025

Feb 13, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENFN, AZPN, HEES, NEUE on Behalf of Shareholders - Marketscreener.com

Feb 13, 2025

Feb 11, 2025

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into NeueHealth Inc. ("NEUE"). - Morningstar

Feb 11, 2025

Levi & Korsinsky, LLP Notifies Investors of an Investigation into NeueHealth Inc. ("NEUE"). - Marketscreener.com

Feb 11, 2025

Feb 09, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating NeueHealth, Inc. (NEUE) And Encourages Shareholders to Connect - ACCESS Newswire

Feb 09, 2025

Feb 08, 2025

SHAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The MergerAVAV, LTRPA, NEUE, SDIG - The Malaysian Reserve

Feb 08, 2025

Feb 04, 2025

New Enterprise Associates, Inc. entered into an Agreement and Plan of Merger to acquire remaining 66.96% stake in NeueHealth, Inc. from a group of shareholders. - Marketscreener.com

Feb 04, 2025

Feb 03, 2025

Short Interest in NeueHealth, Inc. (NYSE:NEUE) Drops By 54.0% - MarketBeat

Feb 03, 2025

Feb 02, 2025

NeueHealth (NYSE:NEUE) Trading Down 0.1%Here's Why - MarketBeat

Feb 02, 2025

Jan 30, 2025

NeueHealth (NYSE:NEUE) Stock Price Down 0.1% – Here’s What Happened - Defense World

Jan 30, 2025

Jan 28, 2025

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates LBRDA, OMIC, NEUE, RSLS on Behalf of Shareholders - The Malaysian Reserve

Jan 28, 2025

Jan 24, 2025

NEUE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces an Investigation into NeueHealth, Inc. and Encourages Investors to Contact the Firm - ACCESS Newswire

Jan 24, 2025

Jan 21, 2025

NeueHealth to be taken private by New Enterprise Associates in $1.3 billion deal - MSN

Jan 21, 2025

Jan 19, 2025

NeueHealth to Be Taken Private by New Enterprise Associates in $1.3 Billion Deal - MSN

Jan 19, 2025

Jan 13, 2025

Kuehn Law Encourages CCNE, USAP, ML, and BTTR Investors to Contact Law Firm - The Malaysian Reserve

Jan 13, 2025

Jan 12, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against NeueHealth, Inc. (NEUE) And Encourages Stockholders to Reach Out - AccessWire

Jan 12, 2025

Jan 10, 2025

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates GETY, CLBR, VINC, NEUE on Behalf of Shareholders - GlobeNewswire Inc.

Jan 10, 2025

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates GETY, CLBR, VINC, NEUE on Behalf of Shareholders - GlobeNewswire

Jan 10, 2025

Jan 09, 2025

neuehealth CFO Jay Matushak sells $36,430 in stock By Investing.com - Investing.com South Africa

Jan 09, 2025

Neuehealth EVP Tomas Orozco sells shares worth $9,037 By Investing.com - Investing.com Nigeria

Jan 09, 2025

Neuehealth CEO sells shares worth $233,079 By Investing.com - Investing.com South Africa

Jan 09, 2025

Jan 08, 2025

neuehealth CFO Jay Matushak sells $36,430 in stock - Investing.com India

Jan 08, 2025

NeueHealth, Inc. (NYSE:NEUE) CEO George Lawrence Mikan III Sells 31,798 Shares - MarketBeat

Jan 08, 2025

NeueHealth, Inc. (NYSE:NEUE) CAO Sells $10,027.44 in Stock - MarketBeat

Jan 08, 2025

Insider Selling: NeueHealth, Inc. (NYSE:NEUE) Insider Sells 2,486 Shares of Stock - MarketBeat

Jan 08, 2025

Neuehealth EVP Tomas Orozco sells shares worth $9,037 - Investing.com India

Jan 08, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating NeueHealth, Inc. (NEUE) And Encourages Stockholders to Connect - AccessWire

Jan 08, 2025

NeueHealth chief accounting officer sells $10,027 in stock By Investing.com - Investing.com Nigeria

Jan 08, 2025

NeueHealth chief accounting officer sells $10,027 in stock - Investing.com

Jan 08, 2025

Neuehealth gc sells shares worth $18,222 - Investing.com

Jan 08, 2025

Neuehealth CEO sells shares worth $233,079 - Investing.com

Jan 08, 2025

Jan 07, 2025

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of NeueHealth, Inc.NEUE - Kilgore News Herald

Jan 07, 2025

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates VINC, MHLD, NEUE on Behalf of Shareholders - Marketscreener.com

Jan 07, 2025

Jan 06, 2025

NEUEHEALTH INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NeueHealth, Inc.NEUE - Marketscreener.com

Jan 06, 2025

NeueHealth to become a private company after $1.3B acquisition - Mobihealth News

Jan 06, 2025

Jan 05, 2025